ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,3,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2,5,Oral mucosa atrophy,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2,6,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
4,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
6,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
6,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
8,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
9,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
9,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,3,Serositis,Inflammations,General system disorders NEC,Genrl,N
10,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
10,2,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
11,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
12,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
12,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
13,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
14,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
15,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
16,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
16,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
17,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
17,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
18,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
18,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
18,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
20,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
20,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
21,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
22,1,Haemofiltration,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
